Citadel Advisors’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Buy |
20,322
+17,483
| +616% | +$336K | ﹤0.01% | 4323 |
|
|
2025
Q1 | $31.4K | Buy |
2,839
+2,644
| +1,356% | +$29.2K | ﹤0.01% | 5499 |
|
|
2024
Q4 | $3.24K | Hold |
195
| – | – | ﹤0.01% | 5779 |
|
|
2024
Q3 | $1.98K | Sell |
195
-19,372
| -99% | -$197K | ﹤0.01% | 5579 |
|
|
2024
Q2 | $1.13M | Buy |
19,567
+768
| +4% | +$44.4K | ﹤0.01% | 2918 |
|
|
2024
Q1 | $626K | Sell |
18,799
-10,390
| -36% | -$346K | ﹤0.01% | 3656 |
|
|
2023
Q4 | $2.37M | Buy |
29,189
+27,948
| +2,252% | +$2.27M | ﹤0.01% | 2262 |
|
|
2023
Q3 | $202K | Sell |
1,241
-904
| -42% | -$147K | ﹤0.01% | 4544 |
|
|
2023
Q2 | $704K | Sell |
2,145
-22,805
| -91% | -$7.48M | ﹤0.01% | 3317 |
|
|
2023
Q1 | $6.89M | Buy |
24,950
+11,967
| +92% | +$3.3M | ﹤0.01% | 1572 |
|
|
2022
Q4 | $5.03M | Sell |
12,983
-22,188
| -63% | -$8.59M | ﹤0.01% | 1793 |
|
|
2022
Q3 | $8.4M | Sell |
35,171
-18,562
| -35% | -$4.44M | ﹤0.01% | 1412 |
|
|
2022
Q2 | $12M | Sell |
53,733
-1,553
| -3% | -$346K | ﹤0.01% | 1151 |
|
|
2022
Q1 | $37.7M | Buy |
55,286
+1,869
| +3% | +$1.27M | 0.01% | 558 |
|
|
2021
Q4 | $36.9M | Sell |
53,417
-14,519
| -21% | -$10M | 0.01% | 627 |
|
|
2021
Q3 | $50.4M | Buy |
67,936
+23,766
| +54% | +$17.6M | 0.01% | 445 |
|
|
2021
Q2 | $33.1M | Buy |
44,170
+27,527
| +165% | +$20.6M | 0.01% | 684 |
|
|
2021
Q1 | $13.6M | Buy |
16,643
+9,497
| +133% | +$7.75M | ﹤0.01% | 1207 |
|
|
2020
Q4 | $6.09M | Buy |
7,146
+4,984
| +231% | +$4.25M | ﹤0.01% | 1612 |
|
|
2020
Q3 | $1.62M | Buy |
+2,162
| New | +$1.62M | ﹤0.01% | 2478 |
|